Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:1599-1608
Published online before print March 19, 2007, doi: 10.1161/CIRCULATIONAHA.106.603431
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
115/12/1599    most recent
CIRCULATIONAHA.106.603431v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caso, J. R.
Right arrow Articles by Lizasoain, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caso, J. R.
Right arrow Articles by Lizasoain, I.
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Embolic stroke
Right arrow Neuroprotectors
Right arrow Other Stroke Treatment - Medical

(Circulation. 2007;115:1599-1608.)
© 2007 American Heart Association, Inc.


Stroke

Toll-Like Receptor 4 Is Involved in Brain Damage and Inflammation After Experimental Stroke

Javier R. Caso, BSc*; Jesús M. Pradillo, BSc*; Olivia Hurtado, PhD; Pedro Lorenzo, MD, PhD; María A. Moro, PhD; Ignacio Lizasoain, MD, PhD

From the Departamento de Farmacología, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.

Correspondence to Dr Ignacio Lizasoain, Departamento de Farmacología, Facultad de Medicina, Universidad Complutense Madrid, 28040 Madrid, Spain. E-mail ignacio.lizasoain{at}med.ucm.es

Received November 22, 2005; accepted January 5, 2007.

Background— Stroke is the second to third leading cause of death. Toll-like receptor 4 (TLR4) is a signaling receptor in innate immunity that is a specific immunologic response to systemic bacterial infection and cerebral injury. The role of TLR4 in brain ischemia has not been examined yet. We have therefore investigated whether cerebral ischemia and inflammation produced by permanent occlusion of the middle cerebral artery differ in mice that lack a functional TLR4 signaling pathway.

Methods and Results— Permanent occlusion of the middle cerebral artery was performed on 2 strains of TLR4-deficient mice (C3H/HeJ and C57BL/10ScNJ) and respective controls (C3H/HeN and C57BL/10ScSn). Stroke outcome was evaluated by determination of infarct volume and assessment of neurological scores. Brains were collected 24 hours and 7 days after stroke. When compared with control mice, TLR4-deficient mice had lower infarct volumes and better outcomes in neurological and behavioral tests. Mice that lacked TLR4 had minor expression of stroke-induced interferon regulatory factor-1, inducible nitric oxide synthase, and cyclooxygenase-2, mediators implicated in brain damage. The levels of interferon-ß and of the lipid peroxidation marker malondialdehyde were also lower in brains from TLR4-deficient mice than in those from control mice. In addition, the expression of matrix metalloproteinase-9, which is induced and mediates brain damage, was also reduced in TLR4-deficient mice after experimental stroke.

Conclusions— TLR4-deficient mice have minor infarctions and less inflammatory response after an ischemic insult. These data demonstrate that TLR4 signaling and innate immunity are involved in brain damage and in inflammation triggered by ischemic injury.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Carpenter, T. Carlson, J. Dellacasagrande, A. Garcia, S. Gibbons, P. Hertzog, A. Lyons, L.-L. Lin, M. Lynch, T. Monie, et al.
TRIL, a Functional Component of the TLR4 Signaling Complex, Highly Expressed in Brain
J. Immunol., September 15, 2009; 183(6): 3989 - 3995.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Pastor, I. Garcia-Yebenes, N. Fradejas, J. M. Perez-Ortiz, S. Mora-Lee, P. Tranque, M. A. Moro, M. Pende, and S. Calvo
mTOR/S6 Kinase Pathway Contributes to Astrocyte Survival during Ischemia
J. Biol. Chem., August 14, 2009; 284(33): 22067 - 22078.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. Sharma and R. K. Maheshwari
Oligonucleotide array analysis of Toll-like receptors and associated signalling genes in Venezuelan equine encephalitis virus-infected mouse brain
J. Gen. Virol., August 1, 2009; 90(8): 1836 - 1847.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. R. Caso, O. Hurtado, M. P. Pereira, B. Garcia-Bueno, L. Menchen, L. Alou, M. L. Gomez-Lus, M. A. Moro, I. Lizasoain, and J. C. Leza
Colonic bacterial translocation as a possible factor in stress-worsening experimental stroke outcome
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R979 - R985.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
X. Urra, A. Cervera, V. Obach, N. Climent, A. M. Planas, and A. Chamorro
Monocytes Are Major Players in the Prognosis and Risk of Infection After Acute Stroke
Stroke, April 1, 2009; 40(4): 1262 - 1268.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Sobrado, M. P. Pereira, I. Ballesteros, O. Hurtado, D. Fernandez-Lopez, J. M. Pradillo, J. R. Caso, J. Vivancos, F. Nombela, J. Serena, et al.
Synthesis of Lipoxin A4 by 5-Lipoxygenase Mediates PPAR{gamma}-Dependent, Neuroprotective Effects of Rosiglitazone in Experimental Stroke
J. Neurosci., March 25, 2009; 29(12): 3875 - 3884.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. J. Marsh, S. L. Stevens, B. Hunter, and M. P. Stenzel-Poore
Inflammation and the Emerging Role of the Toll-Like Receptor System in Acute Brain Ischemia
Stroke, March 1, 2009; 40(3_suppl_1): S34 - S37.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. A. Babcock, H. Toft-Hansen, and T. Owens
Signaling through MyD88 Regulates Leukocyte Recruitment after Brain Injury
J. Immunol., November 1, 2008; 181(9): 6481 - 6490.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. R. Morales, I. Ballesteros, J. M. Deniz, O. Hurtado, J. Vivancos, F. Nombela, I. Lizasoain, A. Castrillo, and M. A. Moro
Activation of Liver X Receptors Promotes Neuroprotection and Reduces Brain Inflammation in Experimental Stroke
Circulation, September 30, 2008; 118(14): 1450 - 1459.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Cha, Z. Wang, L. Ao, N. Zou, C. A. Dinarello, A. Banerjee, D. A. Fullerton, and X. Meng
Cytokines Link Toll-Like Receptor 4 Signaling to Cardiac Dysfunction After Global Myocardial Ischemia
Ann. Thorac. Surg., May 1, 2008; 85(5): 1678 - 1685.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. R. Caso, J. M. Pradillo, O. Hurtado, J. C. Leza, M. A. Moro, and I. Lizasoain
Toll-Like Receptor 4 Is Involved in Subacute Stress-Induced Neuroinflammation and in the Worsening of Experimental Stroke
Stroke, April 1, 2008; 39(4): 1314 - 1320.
[Abstract] [Full Text] [PDF]